A Meta-Analysis of Efficacy of Micafungin in Comparison to Amphotericin B, Fluconazole, Voriconazole, and Caspofunginfor the Treatment of Aspergillosis and Candidiasis
Main Article Content
Abstract
Background: The increased invasive fungal infections such as aspergillosis and candidiasis in immune compromised individuals calls for the development of effective antifungal agent.
Article Details
Section
Articles
This work is licensed under a Creative Commons Attribution 4.0 International License.